The ACR has suggested some strategies for mitigating the shortage of biopsy needles including the following considerations:
- Procedure Triage
- Needle Conservation
- Inventory and Supply Chain Management
- Case Prioritization
- Delayed Scheduling
- Patient Communication
For more detailed information and an update from the FDA in mid-June please visit this site.
